An article, showing the abilities of the developed by LLC "BIOSOFT.RU" workflow system "From genome to target" in application for lung cancer, was published in Virtual Biology journal: "Master-regulators driving resistance of non-small cell lung cancer cells to p53 reactivator Nutlin-3". The article shows how the workflow system "From genome to target" can detect key master-regulators, responsible for lung cancer cells being resistant to Nutlin-3 and can eventually predict the promising inhibitors, which may serve as possible therapy that should be combined with Nutlin-3 in case of appearance of cancer cell resistance to this drug. The full version of article is available by this link http://virtual-biology.org/vb/article/view/20/0.